Table F-8PTSD symptom reduction (any measure) for exposure therapy compared with control, by type of comparator: Statistics with one study removed, by type of comparator

Study OmittedOverall Estimate95% Confidence Interval
Waitlist
Basoglu, 2007−1.17(−1.47 to −0.88)
Foa, 2005−1.29(−1.58 to −1.00)
Foa, 1999−1.13(−1.40 to −0.85)
Resick, 2002−1.14(−1.48 to −0.80)
Rothbaum, 2005−1.10(−1.36 to −0.84)
Combined−1.16(−1.40 to −0.91)
Usual Care
Asukai, 2010−2.07(−2.97 to −1.17)
Nacasch, 2011−1.49(−2.40 to −0.58)
Combined−1.79(−2.43 to −1.15)

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.